ATE286536T1 - Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen - Google Patents
Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinenInfo
- Publication number
- ATE286536T1 ATE286536T1 AT94929779T AT94929779T ATE286536T1 AT E286536 T1 ATE286536 T1 AT E286536T1 AT 94929779 T AT94929779 T AT 94929779T AT 94929779 T AT94929779 T AT 94929779T AT E286536 T1 ATE286536 T1 AT E286536T1
- Authority
- AT
- Austria
- Prior art keywords
- plasmodium
- vivax
- binding
- binding domains
- polypeptides
- Prior art date
Links
- 241000223960 Plasmodium falciparum Species 0.000 title abstract 3
- 241000223810 Plasmodium vivax Species 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 title abstract 2
- 108090000623 proteins and genes Proteins 0.000 title abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 3
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 210000003936 merozoite Anatomy 0.000 abstract 2
- 102000036068 sialic acid binding proteins Human genes 0.000 abstract 2
- 108091000315 sialic acid binding proteins Proteins 0.000 abstract 2
- 102000025171 antigen binding proteins Human genes 0.000 abstract 1
- 108091000831 antigen binding proteins Proteins 0.000 abstract 1
- 201000004792 malaria Diseases 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11967793A | 1993-09-10 | 1993-09-10 | |
PCT/US1994/010230 WO1995007353A2 (en) | 1993-09-10 | 1994-09-07 | Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE286536T1 true ATE286536T1 (de) | 2005-01-15 |
Family
ID=22385690
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT94929779T ATE286536T1 (de) | 1993-09-10 | 1994-09-07 | Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen |
Country Status (10)
Country | Link |
---|---|
US (3) | US5849306A (de) |
EP (1) | EP0719333B1 (de) |
JP (1) | JPH09502353A (de) |
CN (3) | CN1134173A (de) |
AT (1) | ATE286536T1 (de) |
AU (1) | AU694142B2 (de) |
CA (1) | CA2171193A1 (de) |
DE (1) | DE69434221T2 (de) |
HK (1) | HK1010395A1 (de) |
WO (1) | WO1995007353A2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69434221T2 (de) * | 1993-09-10 | 2006-01-19 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Bindungsdomänen von Plasmodius Vivax und Plasmodium Falciparum Erythrozyten bindenden Proteinen |
US5993827A (en) * | 1993-09-10 | 1999-11-30 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
US6346510B1 (en) | 1995-10-23 | 2002-02-12 | The Children's Medical Center Corporation | Therapeutic antiangiogenic endostatin compositions |
SE9703386D0 (sv) * | 1997-09-19 | 1997-09-19 | Karolinska Innovations Ab | Malaria polypeptides |
US7459524B1 (en) * | 1997-10-02 | 2008-12-02 | Emergent Product Development Gaithersburg Inc. | Chlamydia protein, sequence and uses thereof |
AU2004201615B2 (en) * | 1999-03-04 | 2007-01-25 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-plasmodium compositions and methods of use |
US7025961B1 (en) | 1999-03-04 | 2006-04-11 | The United States Of America As Represented By The Department Of Health And Human Services | Anti-plasmodium composition and methods of use |
JP2002540770A (ja) * | 1999-03-04 | 2002-12-03 | エントレメッド インコーポレイテッド | 抗マラリア原虫組成物および使用法 |
WO2002011756A2 (en) * | 2000-08-07 | 2002-02-14 | Entremed, Inc. | Anti-plasmodium compositions and methods of use |
AU2002338238A1 (en) * | 2001-04-02 | 2002-10-15 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Healt | Plasmodium falciparum erythrocyte binding protein baebl for use as a vaccine |
JP4214225B2 (ja) * | 2001-10-15 | 2009-01-28 | 独立行政法人農業生物資源研究所 | 抗微生物蛋白質、それをコードする遺伝子及びそれらの利用法 |
US7078507B2 (en) * | 2001-11-09 | 2006-07-18 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Synthetic genes for malarial proteins and methods of use |
PE20080428A1 (es) * | 2006-07-18 | 2008-05-15 | Glaxosmithkline Biolog Sa | Vacunas para la malaria |
US7773575B2 (en) * | 2006-07-24 | 2010-08-10 | Harris Corporation | System and method for communicating using a plurality of TDMA mesh networks having efficient bandwidth use |
CN101921337B (zh) * | 2010-07-21 | 2013-05-08 | 上海市疾病预防控制中心 | 间日疟原虫乳酸脱氢酶抗体、相关制备方法、杂交瘤细胞株和应用 |
US8784832B2 (en) * | 2011-08-19 | 2014-07-22 | University Of South Florida (A Florida Non-Profit Corporation) | Synthetic antigen based on the ligand domain of the Plasmodium vivax duffy binding protein |
CN110343161B (zh) * | 2019-07-30 | 2021-08-20 | 暨南大学 | 一种检测恶性疟原虫hrp2和间日疟原虫ldh的结合蛋白组合及其制备方法和应用 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5144007A (en) * | 1988-11-03 | 1992-09-01 | La Jolla Cancer Research Foundation | Thyroid hormone receptor |
US5198347A (en) * | 1990-07-20 | 1993-03-30 | The United States Of America As Represented By The Department Of Health And Human Services | Dna encoding plasmodium vivax and plasmodium knowlesi duffy receptor |
DE69329145D1 (de) * | 1992-03-11 | 2000-09-07 | Kenneth Francis Prendergast | Anti-virale Fusionspeptide |
DE69434221T2 (de) | 1993-09-10 | 2006-01-19 | The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Bindungsdomänen von Plasmodius Vivax und Plasmodium Falciparum Erythrozyten bindenden Proteinen |
US5993827A (en) * | 1993-09-10 | 1999-11-30 | The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins |
-
1994
- 1994-09-07 DE DE69434221T patent/DE69434221T2/de not_active Expired - Fee Related
- 1994-09-07 WO PCT/US1994/010230 patent/WO1995007353A2/en active IP Right Grant
- 1994-09-07 AT AT94929779T patent/ATE286536T1/de not_active IP Right Cessation
- 1994-09-07 JP JP7508825A patent/JPH09502353A/ja active Pending
- 1994-09-07 CA CA002171193A patent/CA2171193A1/en not_active Abandoned
- 1994-09-07 AU AU78721/94A patent/AU694142B2/en not_active Revoked
- 1994-09-07 CN CN94193335A patent/CN1134173A/zh active Pending
- 1994-09-07 EP EP94929779A patent/EP0719333B1/de not_active Expired - Lifetime
-
1995
- 1995-12-07 US US08/568,459 patent/US5849306A/en not_active Expired - Fee Related
-
1998
- 1998-10-05 HK HK98111108A patent/HK1010395A1/xx not_active IP Right Cessation
- 1998-12-11 US US09/210,288 patent/US6392026B1/en not_active Expired - Fee Related
-
2002
- 2002-05-21 US US10/153,273 patent/US6962987B2/en not_active Expired - Fee Related
- 2002-09-05 CN CN02131950A patent/CN1414018A/zh active Pending
- 2002-09-05 CN CN02131951A patent/CN1414102A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
US20020169305A1 (en) | 2002-11-14 |
AU7872194A (en) | 1995-03-27 |
CN1414102A (zh) | 2003-04-30 |
JPH09502353A (ja) | 1997-03-11 |
CA2171193A1 (en) | 1995-03-16 |
CN1134173A (zh) | 1996-10-23 |
US6392026B1 (en) | 2002-05-21 |
US5849306A (en) | 1998-12-15 |
AU694142B2 (en) | 1998-07-16 |
US6962987B2 (en) | 2005-11-08 |
CN1414018A (zh) | 2003-04-30 |
DE69434221D1 (de) | 2005-02-10 |
DE69434221T2 (de) | 2006-01-19 |
WO1995007353A2 (en) | 1995-03-16 |
EP0719333A1 (de) | 1996-07-03 |
HK1010395A1 (en) | 1999-06-17 |
WO1995007353A3 (en) | 1995-06-01 |
EP0719333B1 (de) | 2005-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE286536T1 (de) | Bindungs domänen von plasmodium vivax und plasmodium falciparum erythrozyten-bindenden proteinen | |
WO1996040766A3 (en) | Binding domains from plasmodium vivax and plasmodium falciparum erythrocyte binding proteins | |
DK0833649T3 (da) | Proteinhydrolysatpræparater til forebyggelse eller behandling af allergier og fremgangsmåder til fremstilling og anvendelser deraf | |
DK1854471T3 (da) | Apolipoprotein A-I-agonister og anvendelse deraf til behandling af dyslipidæmiske forstyrrelser | |
ATE212378T1 (de) | Stressproteine und ihre verwendung | |
DK1032662T3 (da) | Fremgangsmåder og sammensætninger til immunmodulation | |
EP1264890A3 (de) | Plasmodium vivax Blutphaseantigene, dagegen gerichtete Antikörper und diagnostische Verfahren | |
DK0839196T3 (da) | Humant CTLA-8 og anvendelser af CTLA-8-relaterede proteiner | |
DE69026022D1 (de) | Membrane hergestellt aus Copolymeren von Polyimiden und aliphatischen Polyestern . | |
WO2002011756A3 (en) | Anti-plasmodium compositions and methods of use | |
DK124087A (da) | Immunogent peptidantigen svarende til plasmodium vivax circumsporozoitprotein | |
DE3583347D1 (de) | Klonieren von dna fuer protozoenantigene. | |
GR3036782T3 (en) | Proteases capable of shedding the soluble TNF-receptor and TNF-R derived peptides and antibodies against the proteases inhibiting the shedding. | |
ATE331037T1 (de) | Isoliertes frpb nukleinsäuremolekül und entsprechende impfstoff | |
ATE256183T1 (de) | Neue proteine von parasitischen würmern | |
ES2129426T3 (es) | Polipeptidos antitrombinicos. | |
DE60036555D1 (de) | Polypeptidfragmente mit einem c-terminalen teil von katalase aus helicobacter | |
DE59406332D1 (de) | Niedrigviskose wässrige konzentrate von betaintensiden | |
DE69413009D1 (de) | Verwendung von antikörpern gegen pdgf-rezeptoren zur inhibierung von hyperplasie der intima | |
WO1995008631A3 (en) | Target antigens of transmission blocking antibodies for malaria parasites | |
MY104081A (en) | Rhoptry membrane antigen of plasmodium falciparum. | |
WO2000052056A3 (en) | Anti-plasmodium compositions and methods of use | |
IT1270941B (it) | Peptidi di hcv e loro usi. | |
WO2004052914A3 (en) | Compositions and methods for inhibiting malaria protease falcipain-2 | |
方军 et al. | Observation on the specific binding site of p195 protein on human erythrocytes using colloidal gold labelling |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |